In the present study we have analyzed the impact of modified MRSA screening of carriers and patients on epidemiological situation of MRSA Krystyna Paszko 
Introduction
Methicillin resistant Staphylococcus aureus (MRSA) is one of the most common pathogens responsible for hospital infections and, as recently discovered, also for community acquired infections. It can cause a broad spectrum of infections through local invasion, toxin mediated diseases to generalized infections. S. aureus is a bacterium commonly present in the human population and constant or part time carrier frequency in the nasal vestibule is estimated at 30-60% [6] , [8] , [19] , [26] . Therapeutic problems are mainly caused by infections with strains, which are resistant not only to methicillin (methicillin-resistant S. aureus, MRSA) and in consequence to all β-lactam antibiotics but also to many other group of antimicrobial therapeutics. The presence of this pathogen enables its local distribution e.g. within a hospital ward and/or between hospital wards (hospital or healthcare acquired) HA-MRSA [2] , [12] , [13] , [22] , [23] . When such a strain carries genes responsible for the resistance to many antibiotics, as in the in case of HA-MRSA strains [2] , [7] , [12] , [13] , [22] , [23] ; then it becomes a great problem both, therapeutically -due to the limited number of antibiotics available, as well as economically -due to the necessity of expensive drugs and the prolonged time spent in the hospital [4] , [5] , [9] , [10] , [15] , [21] , [25] . The increase of costs is also a result of special procedure initiations needed for controlling the wide-spread of the pathogen, such as hygienic and isolation procedures, identifying the carrier and, next, its eradication [1] , [13] , [17] . In some countries MRSA can constitute up to 80% of all S. aureus isolates in hospitals [14] . In some Polish hospitals the percentage of MRSA strains reached up to~60% [20] . The frequency of bacteremia of this etiology, according to research carried out in the years 1999-2000 in Europe, depending on the country ranged from 44.4% (Greece) to 0.6% (Denmark and the Netherlands) [24] . According to the research of SENTRY carried out in the years 1997-1999 in USA, Canada, Latin America, and Western Pacific, the percentage of infection in these areas was 25.3; 19.2; 20.6 and 21.6, respectively [3] . In our study we have analyzed the impact of modified procedures on epidemiological situation of MRSA during the last three years comparing two similar hospitals in Northern Poland.
Material and methods
A three-year-lasting period (2008-2010) was analyzed. Only the first isolate from one patient and no duplicate were taken into account.
Hospital no. 1
Gdansk is the city that lies on the southern edge of Gdansk Bay (of the Baltic Sea), in a conurbation with the city of Gdynia, spa town of Sopot, and suburban communities, which together form a metropolitan area called the Tricity (Trójmiasto), with a population of over 800,000. Gdansk itself has a population of 455,830 (June 2010), making it the largest city in the Pomerania region of Northern Poland. The 608-bed regional hospital contains three internal departments, cardiology, neurology, pediatric ward, surgery, orthopedic, ICU (adult), ICU neonatal, obstetrics and gynecology, neonatology, laryngology, ophthalmic ward and dialysis unit. The yearly admittance rate and average hospitalization time are presented in Table 1 and Table 2 . Population of the citizens with access to this hospital is estimated on the level of 205,000. Bacteriology lab has an access to the analytical software WHONET (WHO) and VITEK (BioMerieux, France). The modified epidemiological procedure concerning MRSA carriers and patients (Procedure 1) has been implemented within the hospital. Procedure 1 is characterized by the following criteria:
• Epidemiological procedure concerning initial MRSA, VISA or VRSA isolation.
• Patient suspected of being infected (colonized) with MRSA, should be placed in a separate room, may be provided with other patients who have had the presence of a strain.
• The patients prescribed to eradication treatment should not be cohorted.
• The epidemiological investigation is being performed to determine the origin of the strain. • In the case of hospital-acquired infections, the highrisk patients are being screened with microbiological tests (nasal-throat, respiratory tract and rectal isolations).
• The employed medical staff is trained over the prophylaxis of MRSA, VISA and VRSA infections.
• The verification of the established epidemiological procedures is performed. Table 3 and Table 4 . Bacteriology lab has an access to the analytical software Marcel.
The modified epidemiological procedure concerning MRSA carriers and patients (Procedure 2) has been employed implemented in the hospital. • In order to identify carriers and patients infected with MRSA/VRSA material for microbiological examination should be collected from the nasal vestibule or perineum, or groin, or areas of the affected skin; material for a directed search towards VRE identification should be sampled from the anal area (or a stool sample) or the perineum, lesions of the damaged skin or the cathetered patient's urine sample • Patients, who have had contact with microbiologically diagnosed MRSA/VRSA/VRE infected patient or MRSA/ VRSA/VRE carrier, should be cohorted • If a patient is diagnosed as MRSA/VRSA/VRE carrier and if allowed by the clinical condition, the patient should be discharged with recommendations for further treatment aimed at eliminating the carrier statecontrol swabs should be taken for at least 5 days after the procedure eliminating carrier state; it is advisable to obtain a 3-time negative results • The re-taking of the patient to the hospital or taking a patient previously hospitalized in other wards/hospitals, where endemic or epidemic presence of MRSA/ VRSA/VRE was recorded, it is advisable to carry out directed microbial diagnostics; until the results are obtained, strict adherence to the principles of insulation of directly transmitted infections must be applied • Staff colonized with MRSA/VRSA/VRE should be removed from contact with patients, until elimination of the carrier state; before taking the job a microbiological control of the MRSA/VRSA/VRE carrier state should be performed, especially in the personnel previously employed in hospitals where the MRSA/VRSA/VRE were registered.
Results
According to comparative analysis performed for two regional hospitals of Northern Poland with similar bed numbers (608 vs. 609) and similar ward profiles, the percentage of MRSA distribution was different. In 2008 at hospital no. 1 the rate of MRSA to all S. aureus isolates was 14.4% and at hospital no. 2 the same rate was 6.0%. In 2009 these rates were 8.3% and 4.7%, respectively. However, in 2010, the rate was similar for the two described hospitals (Table 2 and Table 4 ). The differences concern also the number of hospitalized patients, hospitalization time and number of microbiological tests performed (Table 1 and Table 3 ). At hospital no. 1 the number of hospitalized patients was approx. 25,000, the hospitalization time was 6.6-6.7 days with percentage of patients' beds occupation of approx. 75%. At hospital no. 2 the number of hospitalized patients was higherca. 31,000, nevertheless the average hospitalization time was shorter and was calculated as 4. 
Discussion
In the last decade in Poland, the monitoring of MRSA infections and carriers has been improved [11] , [16] . Previously some health-associated centers introduced the survey, and epidemiological procedures concerning MRSA carriers and patients [11] , [13] , [18] . 
